documents: FDA-2019-N-5192-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-N-5192-0004 FDA FDA-2019-N-5192 Reference 3 - BPAC-07.18.18-07.19.18-Meeting-Issue-Summary-Reclassification-of-HIV-Point-of-Care-and-Laboratory-based-serological-and-NAT-diagnostic-devices re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests Supporting & Related Material Background Material 2020-02-21T05:00:00Z 2020 2     2020-02-24T00:10:37Z   0 0 0900006484399cd0

Links from other tables